Association of Apolipoprotein E Gene Polymorphism with Ischemic Stroke in Coronary Heart Disease Patients Treated with Medium-intensity Statins

Ping Lv,* Yaofu Zheng,* Jun Huang, Junsong Ke, Hongyu Zhang Department of Cardiology, The First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi 330006, People’s Republic of China*These authors contributed equally to this workCorrespondence: Jun HuangDepartment of Cardiology,...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Lv P, Zheng Y, Huang J, Ke J, Zhang H
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2020
Materias:
Acceso en línea:https://doaj.org/article/96b540f64377426f91ab7551fbe69fa6
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:96b540f64377426f91ab7551fbe69fa6
record_format dspace
spelling oai:doaj.org-article:96b540f64377426f91ab7551fbe69fa62021-12-02T12:09:10ZAssociation of Apolipoprotein E Gene Polymorphism with Ischemic Stroke in Coronary Heart Disease Patients Treated with Medium-intensity Statins1178-2021https://doaj.org/article/96b540f64377426f91ab7551fbe69fa62020-10-01T00:00:00Zhttps://www.dovepress.com/association-of-apolipoprotein-e-gene-polymorphism-with-ischemic-stroke-peer-reviewed-article-NDThttps://doaj.org/toc/1178-2021Ping Lv,* Yaofu Zheng,* Jun Huang, Junsong Ke, Hongyu Zhang Department of Cardiology, The First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi 330006, People’s Republic of China*These authors contributed equally to this workCorrespondence: Jun HuangDepartment of Cardiology, The First Affiliated Hospital of Nanchang University, 17 Yongwaizheng St, Nanchang, Jiangxi 330006, People’s Republic of ChinaTel +86-138 70057352Fax +86-791-88694579Email junhuang918@163.comObjective: To study the association of apolipoprotein E(APOE) gene polymorphism with ischemic stroke (IS) in coronary heart disease (CHD) patients treated with medium-intensity statins.Methods: The retrospective study was performed on 662 samples including 169 CHD subjects complicated with IS, 296 subjects with CHD, and 197 control subjects. The APOE gene was obtained from case files. Univariable and multivariable logistic regression analyses were utilized to recognize the possible risks of CHD and IS.Results: The frequency of ϵ3-ϵ4 genotype was increased in the CHD group (p=0.013) and CHD-IS group (p=0.001), the frequency of ϵ4 allele was also increased in the CHD group (p=0.047) and the CHD-IS group (p=0.009) compared with control group. ϵ3-ϵ4 genotype was the independent risk for CHD and CHD-IS after adjusting for traditional risk factors with adjusted odds ratio (AOR) 2.210, 95%CI: 1.263– 3.867, p=0.005) and (AOR 2.794, 95%CI: 1.539– 5.072, p=0.002). The ϵ4 allele was also significantly associated with CHD (AOR 2.126, 95%CI: 1.265– 3.575,=0.004) and CHD-IS (AOR 2.740, 95%CI: 1.569– 4.784, p=0.001).Conclusion: These results demonstrated that ϵ4 allele influenced the development of CHD with or without IS, especially for the genotype of ϵ3-ϵ4. CHD patients carrying the ϵ3-ϵ4 genotype and the ϵ4 allele were significantly associated with the incidence of IS, even if medium-intensity statins had been used.Keywords: apolipoprotein E, polymorphism, coronary heart disease, ischemic stroke, statinsLv PZheng YHuang JKe JZhang HDove Medical Pressarticleapolipoprotein epolymorphismcoronary heart diseaseischemic strokestatinsNeurosciences. Biological psychiatry. NeuropsychiatryRC321-571Neurology. Diseases of the nervous systemRC346-429ENNeuropsychiatric Disease and Treatment, Vol Volume 16, Pp 2459-2466 (2020)
institution DOAJ
collection DOAJ
language EN
topic apolipoprotein e
polymorphism
coronary heart disease
ischemic stroke
statins
Neurosciences. Biological psychiatry. Neuropsychiatry
RC321-571
Neurology. Diseases of the nervous system
RC346-429
spellingShingle apolipoprotein e
polymorphism
coronary heart disease
ischemic stroke
statins
Neurosciences. Biological psychiatry. Neuropsychiatry
RC321-571
Neurology. Diseases of the nervous system
RC346-429
Lv P
Zheng Y
Huang J
Ke J
Zhang H
Association of Apolipoprotein E Gene Polymorphism with Ischemic Stroke in Coronary Heart Disease Patients Treated with Medium-intensity Statins
description Ping Lv,* Yaofu Zheng,* Jun Huang, Junsong Ke, Hongyu Zhang Department of Cardiology, The First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi 330006, People’s Republic of China*These authors contributed equally to this workCorrespondence: Jun HuangDepartment of Cardiology, The First Affiliated Hospital of Nanchang University, 17 Yongwaizheng St, Nanchang, Jiangxi 330006, People’s Republic of ChinaTel +86-138 70057352Fax +86-791-88694579Email junhuang918@163.comObjective: To study the association of apolipoprotein E(APOE) gene polymorphism with ischemic stroke (IS) in coronary heart disease (CHD) patients treated with medium-intensity statins.Methods: The retrospective study was performed on 662 samples including 169 CHD subjects complicated with IS, 296 subjects with CHD, and 197 control subjects. The APOE gene was obtained from case files. Univariable and multivariable logistic regression analyses were utilized to recognize the possible risks of CHD and IS.Results: The frequency of ϵ3-ϵ4 genotype was increased in the CHD group (p=0.013) and CHD-IS group (p=0.001), the frequency of ϵ4 allele was also increased in the CHD group (p=0.047) and the CHD-IS group (p=0.009) compared with control group. ϵ3-ϵ4 genotype was the independent risk for CHD and CHD-IS after adjusting for traditional risk factors with adjusted odds ratio (AOR) 2.210, 95%CI: 1.263– 3.867, p=0.005) and (AOR 2.794, 95%CI: 1.539– 5.072, p=0.002). The ϵ4 allele was also significantly associated with CHD (AOR 2.126, 95%CI: 1.265– 3.575,=0.004) and CHD-IS (AOR 2.740, 95%CI: 1.569– 4.784, p=0.001).Conclusion: These results demonstrated that ϵ4 allele influenced the development of CHD with or without IS, especially for the genotype of ϵ3-ϵ4. CHD patients carrying the ϵ3-ϵ4 genotype and the ϵ4 allele were significantly associated with the incidence of IS, even if medium-intensity statins had been used.Keywords: apolipoprotein E, polymorphism, coronary heart disease, ischemic stroke, statins
format article
author Lv P
Zheng Y
Huang J
Ke J
Zhang H
author_facet Lv P
Zheng Y
Huang J
Ke J
Zhang H
author_sort Lv P
title Association of Apolipoprotein E Gene Polymorphism with Ischemic Stroke in Coronary Heart Disease Patients Treated with Medium-intensity Statins
title_short Association of Apolipoprotein E Gene Polymorphism with Ischemic Stroke in Coronary Heart Disease Patients Treated with Medium-intensity Statins
title_full Association of Apolipoprotein E Gene Polymorphism with Ischemic Stroke in Coronary Heart Disease Patients Treated with Medium-intensity Statins
title_fullStr Association of Apolipoprotein E Gene Polymorphism with Ischemic Stroke in Coronary Heart Disease Patients Treated with Medium-intensity Statins
title_full_unstemmed Association of Apolipoprotein E Gene Polymorphism with Ischemic Stroke in Coronary Heart Disease Patients Treated with Medium-intensity Statins
title_sort association of apolipoprotein e gene polymorphism with ischemic stroke in coronary heart disease patients treated with medium-intensity statins
publisher Dove Medical Press
publishDate 2020
url https://doaj.org/article/96b540f64377426f91ab7551fbe69fa6
work_keys_str_mv AT lvp associationofapolipoproteinegenepolymorphismwithischemicstrokeincoronaryheartdiseasepatientstreatedwithmediumintensitystatins
AT zhengy associationofapolipoproteinegenepolymorphismwithischemicstrokeincoronaryheartdiseasepatientstreatedwithmediumintensitystatins
AT huangj associationofapolipoproteinegenepolymorphismwithischemicstrokeincoronaryheartdiseasepatientstreatedwithmediumintensitystatins
AT kej associationofapolipoproteinegenepolymorphismwithischemicstrokeincoronaryheartdiseasepatientstreatedwithmediumintensitystatins
AT zhangh associationofapolipoproteinegenepolymorphismwithischemicstrokeincoronaryheartdiseasepatientstreatedwithmediumintensitystatins
_version_ 1718394703538290688